Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label mortality. Show all posts
Showing posts with label mortality. Show all posts
Monday, May 28, 2012

paywalled: Bevacizumab-induced perforation of the gastrointestinal tract: clinical and radiographic findings in 11 patients

›
Bevacizumab-induced perforation of the gastrointestinal tract: clinical and radiographic findings in 11 patients : Abstract Aim To pr...
Saturday, March 17, 2012

abstract: Does Significant Medical Comorbidity Negate the Benefit of Up-front Cytoreduction in Advanced Ovarian Cancer?

›
Does Significant Medical Comorbidity Negate the Benefit of Up-front Cytoreduction in Advanced Ovarian Cancer? Background: The objective o...
Tuesday, March 13, 2012

YouTube: Interview with Dr Stukel, Author of Hospital Spending Intensity and Patient Outcomes

›
Also, planning a comparison study with London School of Economics and Havard
Sunday, March 11, 2012

Outcomes of surgical management of bowel obstruction in relapsed epithelial ovarian cancer (EOC)

›
Outcomes of surgical management of bowel obstruction in relapsed epithelial ovarian cancer (EOC) : Objective  To describe the outcomes of...
Saturday, January 21, 2012

abstract: Natural history and outcome of mucinous carcinoma of the ovary (women dx'd 1988 to 2007)

›
Blogger's Note : this conclusion therefore begs an obvious question OBJECTIVE: We performed a population-based analysis to compare...
Wednesday, January 04, 2012

Effect of Screening on Ovarian Cancer Mortality, June 8, 2011 — JAMA

›
Thursday, December 29, 2011

Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer

›
Monday, August 08, 2011

full free access: Survival of patients with ovarian cancer in central and northern Denmark, 1998–2009

›
Objective To examine time trends of survival and mortality of ovarian cancer in the central and northern Denmark regions during th...
Wednesday, February 23, 2011

Treatment-Related Mortality With Bevacizumab in Cancer Patients, February 2, 2011— JAMA review - 2.5 vs 1.7 % risk not dependent on type of solid tumor/dose

›
Data Synthesis: A total of 10 217 patients with a variety of advanced solid tumors from 16 RCTs were included in the analysis. The overal...
Wednesday, July 28, 2010

Racial differences in stage at diagnosis and survival from epithelial ovarian cancer: A fundamental cause of disease approach

›
Social Science & Medicine abstract: Associations between race, socioeconomic status (SES) and health outcomes have been well establi...
Wednesday, May 05, 2010

Cervical, Uterine Corpus, and Ovarian Cancer Mortality in Greece During 1980 to 2005: A Trend Analysis

›
"The increasing trend of uterine corpus and ovarian cancer mortality in older women suggests that development of well-organized tertia...
Thursday, January 28, 2010

The Practice of Gastrostomy Tube Placement Across a Canadian Regional Health Authority

›